PRNewsWire
13 Jul 2026, 04:00 UTC · 2h ago
Antengene Announces Receipt of USD 60 Million Upfront Payment from UCB
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
PRNewsWire
13 Jul 2026, 04:00 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Antengene has received a USD 60 million upfront payment from UCB as part of a worldwide exclusive license agreement for ATG-201. — A significant immediate cash infusion improves the company's liquidity and provides external validation of its lead asset's value.
+0.60Antengene is eligible for additional near-term milestone payments of USD 20 million, plus future development and commercial milestones and tiered royalties. — Creates potential for future high-margin revenue streams beyond the initial upfront payment.
+0.40China's NMPA approved the Investigational New Drug (IND) application for the Phase I study of ATG-201 for B cell related autoimmune diseases in June. — Regulatory approval to move into clinical trials reduces technical risk and is a prerequisite for asset commercialization.
+0.30Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
The company received a USD 60 million upfront payment and strengthened its cash position through a licensing agreement.
The company secured a worldwide exclusive license for a promising CD19/CD3 bispecific T-cell engager antibody.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
6h ago
